Proquad vials
Ended Awarded Last action
- Contract number
- SPE2DR26FA1K3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,828
Award facts
- Contract value 100% obligated
- $13,827.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,827.85 to AmerisourceBergen Drug Corp for ProQuad vials on January 6, 2026, with an ultimate completion date of January 28, 2026. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, continues to fulfill critical medical supply requirements for federal agencies through its extensive portfolio of competitively awarded contracts. The ProQuad vials delivery supports the Defense Health Agency and other military treatment facilities' immunization programs. As a subsidiary of Cencora, Inc., the company leverages its comprehensive distribution capabilities to supply brand-name and generic pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains to support the Department of Defense healthcare mission.
Quick answers
Who was awarded contract SPE2DR26FA1K3?
SPE2DR26FA1K3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FA1K3 worth?
The government has obligated $13,828 on SPE2DR26FA1K3.
Is contract SPE2DR26FA1K3 an order under another contract?
Yes. SPE2DR26FA1K3 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA1K3 competed?
The extent of competition for SPE2DR26FA1K3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award